Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Improving ethnic and racial diversity in biomarker-driven clinical trials: A proof of concept with the BASECAMP-1 master prescreening study of patients with high-risk solid tumors with human leukocyte antigen-A*02 (HLA-A*02) loss of heterozygosity (LOH)
Improving ethnic and racial diversity in biomarker-driven clinical trials: A proof of concept with the BASECAMP-1 master prescreening study of patients with high-risk solid tumors with human leukocyte antigen-A*02 (HLA-A*02) loss of heterozygosity (LOH) Smith, C., Simeone, D. M., Grierson, P., Kirtane, K., Morelli, M., Patel, S., Ulrickson, M. L., Dahiya, S., Park, J., Specht, J. M., Fakih, M., Liechty, K. B., Tebbets, J., Welch, J., Go, W. Y., Maloney, D. G., Maus, M., Ng, E., Hecht, J. LIPPINCOTT WILLIAMS & WILKINS. 2024View details for Web of Science ID 001275557400329